Literature DB >> 17569896

Tamiflu and neuropsychiatric disturbance in adolescents.

Simon R J Maxwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17569896      PMCID： PMC1892497          DOI： 10.1136/bmj.39240.497025.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.

Authors:  Nicola J Cooper; Alexander J Sutton; Keith R Abrams; Allan Wailoo; David Turner; Karl G Nicholson
Journal:  BMJ       Date:  2003-06-07

2.  Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population.

Authors:  P H Peters; S Gravenstein; P Norwood; V De Bock; A Van Couter; M Gibbens; T A von Planta; P Ward
Journal:  J Am Geriatr Soc       Date:  2001-08       Impact factor: 5.562

Review 3.  Antivirals for influenza in healthy adults: systematic review.

Authors:  T Jefferson; V Demicheli; D Rivetti; M Jones; C Di Pietrantonj; A Rivetti
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

4.  Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

Authors:  Laurent Kaiser; Cynthia Wat; Tracy Mills; Paul Mahoney; Penelope Ward; Frederick Hayden
Journal:  Arch Intern Med       Date:  2003-07-28

Review 5.  Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

Authors:  D Turner; A Wailoo; K Nicholson; N Cooper; A Sutton; K Abrams
Journal:  Health Technol Assess       Date:  2003       Impact factor: 4.014
  5 in total
  22 in total

Review 1.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

2.  Oseltamivir's adverse reactions: Fifty sudden deaths may be related to central suppression.

Authors:  Rokuro Hama
Journal:  BMJ       Date:  2007-07-14

3.  Limited inhibitory effects of oseltamivir and zanamivir on human sialidases.

Authors:  Keiko Hata; Koichi Koseki; Kazunori Yamaguchi; Setsuko Moriya; Yasuo Suzuki; Sangchai Yingsakmongkon; Go Hirai; Mikiko Sodeoka; Mark von Itzstein; Taeko Miyagi
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

4.  Antiviral properties, metabolism, and pharmacokinetics of a novel azolo-1,2,4-triazine-derived inhibitor of influenza A and B virus replication.

Authors:  Inna Karpenko; Sergey Deev; Oleg Kiselev; Valerey Charushin; Vladimir Rusinov; Eugeney Ulomsky; Ella Deeva; Dmitry Yanvarev; Alexander Ivanov; Olga Smirnova; Sergey Kochetkov; Oleg Chupakhin; Marina Kukhanova
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

Review 5.  Antivirals for influenza: strategies for use in pediatrics.

Authors:  Steven M Smith; John G Gums
Journal:  Paediatr Drugs       Date:  2010-10-01       Impact factor: 3.022

Review 6.  Use of oseltamivir in children.

Authors:  Blake Jamieson; Rini Jain; Bruce Carleton; Ran D Goldman
Journal:  Can Fam Physician       Date:  2009-12       Impact factor: 3.275

7.  Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.

Authors:  Aeron C Hurt; Jessica K Holien; Michael W Parker; Ian G Barr
Journal:  Drugs       Date:  2009       Impact factor: 9.546

8.  Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.

Authors:  David W Kimberlin; Marwan Shalabi; Mark J Abzug; David Lang; Richard F Jacobs; Gregory Storch; John S Bradley; Kelly C Wade; Octavio Ramilo; José R Romero; Mark Shelton; Charles Leach; Judith Guzman-Cottrill; Joan Robinson; Nazha Abughali; Janet Englund; Jill Griffin; Penny Jester; Gretchen A Cloud; Richard J Whitley
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129

9.  Synaptic and behavioral interactions of oseltamivir (Tamiflu) with neurostimulants.

Authors:  Y Izumi; K Tokuda; Ka O'Dell; Cf Zorumski; T Narahashi
Journal:  Hum Exp Toxicol       Date:  2008-12       Impact factor: 2.903

10.  Inhibition of MAO-A and stimulation of behavioural activities in mice by the inactive prodrug form of the anti-influenza agent oseltamivir.

Authors:  Miki Hiasa; Yumiko Isoda; Yasushi Kishimoto; Kenta Saitoh; Yasuaki Kimura; Motomu Kanai; Masakatsu Shibasaki; Dai Hatakeyama; Yutaka Kirino; Takashi Kuzuhara
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.